These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33569319)

  • 1. MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer.
    Zhao S; Hou D; Zheng X; Song W; Liu X; Wang S; Zhou L; Tao X; Lv L; Sun Q; Jin Y; Ding L; Mao L; Wu N
    Transl Lung Cancer Res; 2021 Jan; 10(1):368-380. PubMed ID: 33569319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT-Based Radiomic Signature as a Prognostic Factor in Stage IV
    Li H; Zhang R; Wang S; Fang M; Zhu Y; Hu Z; Dong D; Shi J; Tian J
    Front Oncol; 2020; 10():57. PubMed ID: 32133282
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of anaplastic lymphoma kinase variants and alterations with ensartinib response duration in non-small cell lung cancer.
    Hou D; Zheng X; Song W; Liu X; Wang S; Zhou L; Tao X; Lv L; Sun Q; Jin Y; Zhang Z; Ding L; Wu N; Zhao S
    Thorac Cancer; 2021 Sep; 12(17):2388-2399. PubMed ID: 34288491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomic-signature changes after early treatment improve the prediction of progression-free survival in patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer.
    Hou D; Zheng X; Song W; Liu X; Wang S; Zhou L; Tao X; Lv L; Sun Q; Jin Y; Zhang Z; Ding L; Wu N; Zhao S
    Acta Radiol; 2023 Mar; 64(3):1194-1204. PubMed ID: 35971221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer.
    Jain P; Khorrami M; Gupta A; Rajiah P; Bera K; Viswanathan VS; Fu P; Dowlati A; Madabhushi A
    Front Oncol; 2021; 11():744724. PubMed ID: 34745966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a Radiomic Signature Developed in a General NSCLC Cohort for Predicting Overall Survival of ALK-Positive Patients With Different Treatment Types.
    Huang L; Chen J; Hu W; Xu X; Liu D; Wen J; Lu J; Cao J; Zhang J; Gu Y; Wang J; Fan M
    Clin Lung Cancer; 2019 Nov; 20(6):e638-e651. PubMed ID: 31375452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an MRI-Based nomogram to predict the effectiveness of immunotherapy for brain metastasis in patients with non-small cell lung cancer.
    Xu J; Wang P; Li Y; Shi X; Yin T; Yu J; Teng F
    Front Immunol; 2024; 15():1373330. PubMed ID: 38686383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of contrast-enhanced magnetic resonance imaging-T2WI-based radiomic features in distinguishing lung adenocarcinoma from lung squamous cell carcinoma with solid components >8 mm.
    Yang M; Shi L; Huang T; Li G; Shao H; Shen Y; Zhu J; Ni B
    J Thorac Dis; 2023 Feb; 15(2):635-648. PubMed ID: 36910079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain metastasis receiving tyrosine kinase inhibitors.
    Wang TW; Chao HS; Chiu HY; Lu CF; Liao CY; Lee Y; Chen JR; Shiao TH; Chen YM; Wu YT
    Transl Oncol; 2024 Jan; 39():101826. PubMed ID: 37984256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI Radiomic Features: A Potential Biomarker for Progression-Free Survival Prediction of Patients With Locally Advanced Cervical Cancer Undergoing Surgery.
    Cai M; Yao F; Ding J; Zheng R; Huang X; Yang Y; Lin F; Hu Z
    Front Oncol; 2021; 11():749114. PubMed ID: 34970482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of UTE-MRI-based radiomics model for prediction of histopathologic subtype of lung adenocarcinoma: in comparison with CT-based radiomics model.
    Lee S; Lee CY; Kim NY; Suh YJ; Lee HJ; Yong HS; Kim HR; Kim YJ
    Eur Radiol; 2024 May; 34(5):3422-3430. PubMed ID: 37840100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment Thoracic CT Radiomic Features to Predict Brain Metastases in Patients With
    Wang H; Chen YZ; Li WH; Han Y; Li Q; Ye Z
    Front Genet; 2022; 13():772090. PubMed ID: 35281837
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer.
    Zhuang Z; Liu Z; Li J; Wang X; Xie P; Xiong F; Hu J; Meng X; Huang M; Deng Y; Lan P; Yu H; Luo Y
    J Transl Med; 2021 Jun; 19(1):256. PubMed ID: 34112180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and predictive value of radiomics features at MRI in nasopharyngeal carcinoma.
    Bao D; Zhao Y; Liu Z; Zhong H; Geng Y; Lin M; Li L; Zhao X; Luo D
    Discov Oncol; 2021; 12(1):63. PubMed ID: 34993528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing intracranial efficacy prediction of osimertinib in non-small cell lung cancer: a novel approach through brain MRI radiomics.
    Tang X; Li Y; Qian WL; Han PL; Yan WF; Yang ZG
    Front Neurol; 2024; 15():1399983. PubMed ID: 39281414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer.
    Chen BT; Jin T; Ye N; Mambetsariev I; Wang T; Wong CW; Chen Z; Rockne RC; Colen RR; Holodny AI; Sampath S; Salgia R
    Front Oncol; 2021; 11():621088. PubMed ID: 33747933
    [No Abstract]   [Full Text] [Related]  

  • 17. Using MRI radiomics to predict the efficacy of immunotherapy for brain metastasis in patients with small cell lung cancer.
    Shi X; Wang P; Li Y; Xu J; Yin T; Teng F
    Thorac Cancer; 2024 Mar; 15(9):738-748. PubMed ID: 38376861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma.
    Chang C; Sun X; Wang G; Yu H; Zhao W; Ge Y; Duan S; Qian X; Wang R; Lei B; Wang L; Liu L; Ruan M; Yan H; Liu C; Chen J; Xie W
    Front Oncol; 2021; 11():603882. PubMed ID: 33738250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC.
    Li Q; Xiao Q; Li J; Duan S; Wang H; Gu Y
    Cancer Manag Res; 2020; 12():10603-10613. PubMed ID: 33149669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.